| Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial J Shepherd, GJ Blauw, MB Murphy, ELEM Bollen, BM Buckley, SM Cobbe, ... The lancet 360 (9346), 1623-1630, 2002 | 4464 | 2002 |
| Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis RJ Fox, DH Miller, JT Phillips, M Hutchinson, E Havrdova, M Kita, M Yang, ... New England Journal of Medicine 367 (12), 1087-1097, 2012 | 1560 | 2012 |
| 250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study P O'Connor, M Filippi, B Arnason, G Comi, S Cook, D Goodin, HP Hartung, ... The Lancet Neurology 8 (10), 889-897, 2009 | 515 | 2009 |
| The design of a prospective study of pravastatin in the elderly at risk (PROSPER) J Shepherd, GJ Blauw, MB Murphy, SM Cobbe, ELEM Bollen, BM Buckley, ... The American journal of cardiology 84 (10), 1192-1197, 1999 | 379 | 1999 |
| Testing cognitive function in elderly populations: the PROSPER study PJ Houx, J Shepherd, GJ Blauw, MB Murphy, I Ford, EL Bollen, B Buckley, ... Journal of Neurology, Neurosurgery & Psychiatry 73 (4), 385-389, 2002 | 205 | 2002 |
| Proton spectroscopy of the brain in HIV infection: correlation with clinical, immunologic, and MR imaging findings. WK Chong, B Sweeney, ID Wilkinson, M Paley, MA Hall-Craggs, ... Radiology 188 (1), 119-124, 1993 | 179 | 1993 |
| Association Between Apolipoprotein E4 and Cognitive Decline in Elderly Adults CJ Packard, RGJ Westendorp, DJ Stott, MJ Caslake, HM Murray, ... Journal of the American Geriatrics Society 55 (11), 1777-1785, 2007 | 170 | 2007 |
| Prospective Study of Pravastatin in the Elderly at Risk.(PROSPER) J Shepherd, GJ Bloun, MB Murphy Lancet 360, 1623-30, 2002 | 168 | 2002 |
| C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) N Sattar, HM Murray, A McConnachie, GJ Blauw, ELEM Bollen, ... Circulation 115 (8), 981-989, 2007 | 166 | 2007 |
| Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) CJ Packard, I Ford, M Robertson, J Shepherd, GJ Blauw, MB Murphy, ... Circulation 112 (20), 3058-3065, 2005 | 138 | 2005 |
| Clinical characteristics and outcome of patients diagnosed with psychogenic nonepileptic seizures: a 5-year review SS O’Sullivan, JE Spillane, EM McMahon, BJ Sweeney, RJ Galvin, ... Epilepsy & behavior 11 (1), 77-84, 2007 | 122 | 2007 |
| Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009-December 2010 D O’flanagan, AS Barret, M Foley, S Cotter, C Bonner, C Crowe, B Lynch, ... Eurosurveillance 19 (17), 2014 | 99 | 2014 |
| A Prospective Analysis of Elevated Fasting Glucose Levels and Cognitive Function in Older People Results From PROSPER and the Rotterdam Study SM Euser, N Sattar, JCM Witteman, ELEM Bollen, EJG Sijbrands, ... diabetes 59 (7), 1601-1607, 2010 | 93 | 2010 |
| Evidence of CNS impairment in HIV infection: clinical, neuropsychological, EEG, and MRI/MRS study MJG Harrison, SP Newman, MA Hall-Craggs, CJ Fowler, R Miller, ... Journal of Neurology, Neurosurgery & Psychiatry 65 (3), 301-307, 1998 | 89 | 1998 |
| Localized cerebral proton MR spectroscopy in HIV infection and AIDS. WK Chong, M Paley, ID Wilkinson, MA Hall-Craggs, B Sweeney, ... American journal of neuroradiology 15 (1), 21-25, 1994 | 85 | 1994 |
| Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study DH Miller, RJ Fox, JT Phillips, M Hutchinson, E Havrdova, M Kita, ... Neurology 84 (11), 1145-1152, 2015 | 81 | 2015 |
| Genetic variation in the interleukin‐10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study S Trompet, D Pons, AJM de Craen, P Slagboom, J Shepherd, GJ Blauw, ... Annals of the New York Academy of Sciences 1100 (1), 189-198, 2007 | 79 | 2007 |
| on behalf of the PROSPER study group: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial J Shepherd, GJ Blauw, MB Murphy, EL Bollen, BM Buckley, SM Cobbe, ... Lancet 360, 1623-1630, 2002 | 62 | 2002 |
| Plasma lipoprotein (a)[Lp (a)] concentrations and cardiovascular events in the elderly: evidence from the prospective study of pravastatin in the elderly at risk (PROSPER) A Gaw, HM Murray, EA Brown, PROSPER Study Group Atherosclerosis 180 (2), 381-388, 2005 | 61 | 2005 |
| A prospective study of pravastatin in the elderly at risk (PROSPER): screening experience and baseline characteristics I Ford, GJ Blauw, MB Murphy, J Shepherd, SM Cobbe, ELEM Bollen, ... Current controlled trials in cardiovascular medicine 3, 1-8, 2002 | 53 | 2002 |
